vs
InnovAge Holding Corp.（INNV）与Privia Health Group, Inc.（PRVA）财务数据对比。点击上方公司名可切换其他公司
Privia Health Group, Inc.的季度营收约是InnovAge Holding Corp.的2.3倍（$541.2M vs $239.7M）。InnovAge Holding Corp.净利率更高（4.4% vs 1.7%，领先2.7%）。Privia Health Group, Inc.同比增速更快（17.4% vs 14.7%）。过去两年Privia Health Group, Inc.的营收复合增速更高（14.2% vs 11.4%）
InnovAge Holding Corp是美国领先的老年护理服务商，主要运营老年人全包护理项目（PACE），为符合条件的高龄群体提供综合医疗、社会支持与日常生活协助，帮助老人居家养老，服务覆盖美国多个州。
Privia Health Group, Inc.是总部位于美国的医疗科技与服务企业，为独立诊所、医疗系统和医疗支付方提供价值导向型医疗解决方案，涵盖人群健康管理、患者互动平台、护理协调支持及行政流程优化工具，助力提升诊疗效果、降低医疗参与方运营成本。
INNV vs PRVA — 直观对比
营收规模更大
PRVA
是对方的2.3倍
$239.7M
营收增速更快
PRVA
高出2.7%
14.7%
净利率更高
INNV
高出2.7%
1.7%
两年增速更快
PRVA
近两年复合增速
11.4%
损益表 — Q2 2026 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $239.7M | $541.2M |
| 净利润 | $10.6M | $9.2M |
| 毛利率 | 22.0% | — |
| 营业利润率 | 5.5% | 2.1% |
| 净利率 | 4.4% | 1.7% |
| 营收同比 | 14.7% | 17.4% |
| 净利润同比 | 180.3% | 108.0% |
| 每股收益（稀释后） | $0.08 | $0.08 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收INNVPRVA
| Q4 25 | $239.7M | $541.2M | ||
| Q3 25 | $236.1M | $580.4M | ||
| Q2 25 | $221.4M | $521.2M | ||
| Q1 25 | $218.1M | $480.1M | ||
| Q4 24 | $209.0M | $460.9M | ||
| Q3 24 | $205.1M | $437.9M | ||
| Q2 24 | $199.4M | $422.3M | ||
| Q1 24 | $193.1M | $415.2M |
净利润INNVPRVA
| Q4 25 | $10.6M | $9.2M | ||
| Q3 25 | $8.0M | $6.9M | ||
| Q2 25 | $-785.0K | $2.7M | ||
| Q1 25 | $-11.4M | $4.2M | ||
| Q4 24 | $-13.2M | $4.4M | ||
| Q3 24 | $-4.9M | $3.5M | ||
| Q2 24 | $-1.7M | $3.5M | ||
| Q1 24 | $-5.9M | $3.0M |
毛利率INNVPRVA
| Q4 25 | 22.0% | — | ||
| Q3 25 | 21.8% | — | ||
| Q2 25 | 18.6% | — | ||
| Q1 25 | 18.7% | — | ||
| Q4 24 | 17.7% | — | ||
| Q3 24 | 16.8% | — | ||
| Q2 24 | 18.3% | — | ||
| Q1 24 | 17.6% | — |
营业利润率INNVPRVA
| Q4 25 | 5.5% | 2.1% | ||
| Q3 25 | 3.5% | 2.5% | ||
| Q2 25 | -1.0% | 0.6% | ||
| Q1 25 | -4.7% | 1.1% | ||
| Q4 24 | -6.0% | 1.1% | ||
| Q3 24 | -2.4% | 1.3% | ||
| Q2 24 | -2.4% | 1.2% | ||
| Q1 24 | -3.0% | 0.2% |
净利率INNVPRVA
| Q4 25 | 4.4% | 1.7% | ||
| Q3 25 | 3.4% | 1.2% | ||
| Q2 25 | -0.4% | 0.5% | ||
| Q1 25 | -5.2% | 0.9% | ||
| Q4 24 | -6.3% | 1.0% | ||
| Q3 24 | -2.4% | 0.8% | ||
| Q2 24 | -0.9% | 0.8% | ||
| Q1 24 | -3.0% | 0.7% |
每股收益（稀释后）INNVPRVA
| Q4 25 | $0.08 | $0.08 | ||
| Q3 25 | $0.06 | $0.05 | ||
| Q2 25 | $0.00 | $0.02 | ||
| Q1 25 | $-0.08 | $0.03 | ||
| Q4 24 | $-0.10 | $0.03 | ||
| Q3 24 | $-0.04 | $0.03 | ||
| Q2 24 | $-0.01 | $0.03 | ||
| Q1 24 | $-0.04 | $0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $126.0M | $479.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $256.8M | $737.2M |
| 总资产 | $527.5M | $1.4B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资INNVPRVA
| Q4 25 | $126.0M | $479.7M | ||
| Q3 25 | $109.4M | $441.4M | ||
| Q2 25 | $105.9M | $390.1M | ||
| Q1 25 | $101.7M | $469.3M | ||
| Q4 24 | $86.9M | $491.1M | ||
| Q3 24 | $85.7M | $422.0M | ||
| Q2 24 | $102.8M | $387.4M | ||
| Q1 24 | $99.3M | $351.1M |
总债务INNVPRVA
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $60.0M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $66.0M | — | ||
| Q1 24 | — | — |
股东权益INNVPRVA
| Q4 25 | $256.8M | $737.2M | ||
| Q3 25 | $245.0M | $709.1M | ||
| Q2 25 | $235.0M | $682.9M | ||
| Q1 25 | $238.0M | $659.4M | ||
| Q4 24 | $248.5M | $635.2M | ||
| Q3 24 | $260.9M | $614.9M | ||
| Q2 24 | $269.3M | $595.4M | ||
| Q1 24 | $281.1M | $576.8M |
总资产INNVPRVA
| Q4 25 | $527.5M | $1.4B | ||
| Q3 25 | $510.2M | $1.4B | ||
| Q2 25 | $526.9M | $1.3B | ||
| Q1 25 | $536.6M | $1.2B | ||
| Q4 24 | $524.8M | $1.1B | ||
| Q3 24 | $527.7M | $1.1B | ||
| Q2 24 | $547.7M | $1.1B | ||
| Q1 24 | $527.4M | $1.0B |
负债/权益比INNVPRVA
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.26× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.25× | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $21.4M | $127.5M |
| 自由现金流经营现金流 - 资本支出 | $19.0M | — |
| 自由现金流率自由现金流/营收 | 7.9% | — |
| 资本支出强度资本支出/营收 | 1.0% | — |
| 现金转化率经营现金流/净利润 | 2.01× | 13.93× |
| 过去12个月自由现金流最近4个季度 | $49.4M | — |
8季度趋势，按日历期对齐
经营现金流INNVPRVA
| Q4 25 | $21.4M | $127.5M | ||
| Q3 25 | $3.9M | $52.0M | ||
| Q2 25 | $9.0M | $8.0M | ||
| Q1 25 | $24.6M | $-24.1M | ||
| Q4 24 | $6.8M | $74.8M | ||
| Q3 24 | $-7.5M | $33.2M | ||
| Q2 24 | $1.9M | $34.5M | ||
| Q1 24 | $3.5M | $-33.1M |
自由现金流INNVPRVA
| Q4 25 | $19.0M | — | ||
| Q3 25 | $-153.0K | — | ||
| Q2 25 | $8.8M | — | ||
| Q1 25 | $21.7M | — | ||
| Q4 24 | $5.4M | — | ||
| Q3 24 | $-9.7M | — | ||
| Q2 24 | $-1.4M | — | ||
| Q1 24 | $3.1M | — |
自由现金流率INNVPRVA
| Q4 25 | 7.9% | — | ||
| Q3 25 | -0.1% | — | ||
| Q2 25 | 4.0% | — | ||
| Q1 25 | 10.0% | — | ||
| Q4 24 | 2.6% | — | ||
| Q3 24 | -4.7% | — | ||
| Q2 24 | -0.7% | — | ||
| Q1 24 | 1.6% | — |
资本支出强度INNVPRVA
| Q4 25 | 1.0% | — | ||
| Q3 25 | 1.7% | — | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 1.3% | — | ||
| Q4 24 | 0.6% | — | ||
| Q3 24 | 1.1% | — | ||
| Q2 24 | 1.7% | — | ||
| Q1 24 | 0.2% | — |
现金转化率INNVPRVA
| Q4 25 | 2.01× | 13.93× | ||
| Q3 25 | 0.49× | 7.58× | ||
| Q2 25 | — | 2.97× | ||
| Q1 25 | — | -5.70× | ||
| Q4 24 | — | 17.00× | ||
| Q3 24 | — | 9.38× | ||
| Q2 24 | — | 9.94× | ||
| Q1 24 | — | -11.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
INNV
暂无分部数据
PRVA
| FFS Patient Care | $364.4M | 67% |
| Capitated Revenue | $71.4M | 13% |
| Shared Savings | $46.9M | 9% |
| FFS Administrative Services | $36.0M | 7% |
| Care Management Fee PMPM | $20.0M | 4% |
| Other Revenue | $2.5M | 0% |
